ES2056471T3 - Antagonistas irreversibles de la bombesina. - Google Patents
Antagonistas irreversibles de la bombesina.Info
- Publication number
- ES2056471T3 ES2056471T3 ES90909646T ES90909646T ES2056471T3 ES 2056471 T3 ES2056471 T3 ES 2056471T3 ES 90909646 T ES90909646 T ES 90909646T ES 90909646 T ES90909646 T ES 90909646T ES 2056471 T3 ES2056471 T3 ES 2056471T3
- Authority
- ES
- Spain
- Prior art keywords
- leu
- clch
- gly
- valencia
- phe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002790 bombesin antagonist Substances 0.000 title 1
- 230000002427 irreversible effect Effects 0.000 title 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 abstract 2
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical class [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 1
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
- LESXFEZIFXFIQR-LURJTMIESA-N Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(O)=O LESXFEZIFXFIQR-LURJTMIESA-N 0.000 abstract 1
- -1 PHENYL GROUP Chemical group 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 108010050848 glycylleucine Proteins 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PEPTIDO DE LA FORMULA (I) EN EL CUAL RS ES UN GRUPO DE LA FORMULA: 4-(CLCH$_{2}$CH$_{2}$)$_{2}$N-C$_{6}$H$_{4}$-CO-, 3-(CLCH$_{2}$CH$_{2}$)$_{2}$N-C$_{6}$H$_{4}$-CO-, CLCH$_{2}$CH$_{2}$NHCO-, CLCH = CH-CO-, BRCH = CH-CO, CH$_{2}$ = CCLCO-, CH$_{2}$CBRCO $_{2}$ CH$_{2}$N(NO)CO-, O CLCH$_{2}$CO-CH(R$_{1}$)NHCO(CH$_{2}$)$_{2}$CO-; A = UN ENLACE DE VALENCIA, O GLY, LEU-GLY, ARG-LEU-GLY, GLN-ARG-LEU-GLY; B = VALENCIA DE ENLACE O ASN O THR; C = GLN O HIS; X = GLY O ALA; Y = VALENCIA DE ENLACE O HIS(R$_{2}$), HIS(R$_{2}$), PHE, PHE, SER, SER, ALA O ALA; T = VALENCIA DE ENLACE O LEU, LEU, PHE O PHE; W ES UN GRUPO DE LA FORMULA: OH, NH$_{2}$, NH(CH$_{2}$)$_{4}$CH$_{3}$, H(CH$_{2}$)$_{2}$C$_{6}$H$_{5}$, MET-R$_{3}$, LEU-R$_{3}$, ILE-R$_{3}$, O NLE-R$_{3}$; R$_{1}$ = H, UNA CADENA ALIFATICA LINEAL O RAMIFICADA TENIENDO DE 1 A 11 ATOMOS DE CARBONO , BENZILO O GRUPO FENILO; R$_{2}$ = H O TOS, DNP O BZL Y R$_{3}$ = NH$_{2}$ , OH, OCH$_{3}$ O NHNH$_{2}$, Y LAS SALES FARMACEUTICAMENTE ACEPTABLES SON ANTAGONISTAS DEL BOMBASI. SE DESCRIBE TAMBIEN SU PREPARACION Y LOS COMPUESTOS FARMACEUTICOS QUE LAS CONTIENEN.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898913844A GB8913844D0 (en) | 1989-06-15 | 1989-06-15 | Irreversible bombesin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2056471T3 true ES2056471T3 (es) | 1994-10-01 |
Family
ID=10658532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES90909646T Expired - Lifetime ES2056471T3 (es) | 1989-06-15 | 1990-06-12 | Antagonistas irreversibles de la bombesina. |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP0428700B1 (es) |
| JP (1) | JPH04500371A (es) |
| KR (1) | KR920700223A (es) |
| AU (1) | AU630715B2 (es) |
| CA (1) | CA2034480A1 (es) |
| DE (1) | DE69008674T2 (es) |
| ES (1) | ES2056471T3 (es) |
| GB (1) | GB8913844D0 (es) |
| HU (1) | HUT56118A (es) |
| IE (1) | IE902136A1 (es) |
| IL (1) | IL94692A0 (es) |
| NZ (1) | NZ234011A (es) |
| PT (1) | PT94352A (es) |
| WO (1) | WO1990015819A1 (es) |
| ZA (1) | ZA904591B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU618029B2 (en) * | 1987-11-02 | 1991-12-12 | Imperial Chemical Industries Plc | Polypeptide compounds |
| GB8813356D0 (en) * | 1988-06-06 | 1988-07-13 | Ici Plc | Polypeptide compounds |
| CN101791409A (zh) | 2003-04-22 | 2010-08-04 | 研究及应用科学协会股份有限公司 | 肽载体 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4423236A (en) * | 1980-08-14 | 1983-12-27 | National Foundation For Cancer Research, Inc. | 5,6,-0-Isoalkylidene ascorbic acid derivatives |
| US4331661A (en) * | 1980-10-03 | 1982-05-25 | The Salk Institute For Biological Studies | Bombesin analogs |
| AU618029B2 (en) * | 1987-11-02 | 1991-12-12 | Imperial Chemical Industries Plc | Polypeptide compounds |
-
1989
- 1989-06-15 GB GB898913844A patent/GB8913844D0/en active Pending
-
1990
- 1990-06-11 NZ NZ234011A patent/NZ234011A/xx unknown
- 1990-06-11 IL IL94692A patent/IL94692A0/xx unknown
- 1990-06-12 AU AU58596/90A patent/AU630715B2/en not_active Expired - Fee Related
- 1990-06-12 KR KR1019910700175A patent/KR920700223A/ko not_active Withdrawn
- 1990-06-12 HU HU905381A patent/HUT56118A/hu unknown
- 1990-06-12 ES ES90909646T patent/ES2056471T3/es not_active Expired - Lifetime
- 1990-06-12 JP JP2509710A patent/JPH04500371A/ja active Pending
- 1990-06-12 EP EP90909646A patent/EP0428700B1/en not_active Expired - Lifetime
- 1990-06-12 EP EP90111088A patent/EP0402852A1/en not_active Withdrawn
- 1990-06-12 CA CA002034480A patent/CA2034480A1/en not_active Abandoned
- 1990-06-12 PT PT94352A patent/PT94352A/pt not_active Application Discontinuation
- 1990-06-12 WO PCT/EP1990/000922 patent/WO1990015819A1/en not_active Ceased
- 1990-06-12 DE DE69008674T patent/DE69008674T2/de not_active Expired - Fee Related
- 1990-06-13 ZA ZA904591A patent/ZA904591B/xx unknown
- 1990-06-13 IE IE213690A patent/IE902136A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU905381D0 (en) | 1991-06-28 |
| EP0402852A1 (en) | 1990-12-19 |
| DE69008674D1 (de) | 1994-06-09 |
| EP0428700B1 (en) | 1994-05-04 |
| ZA904591B (en) | 1991-03-27 |
| IE902136A1 (en) | 1991-01-02 |
| HUT56118A (en) | 1991-07-29 |
| PT94352A (pt) | 1991-02-08 |
| KR920700223A (ko) | 1992-02-19 |
| DE69008674T2 (de) | 1994-09-15 |
| IE902136L (en) | 1990-12-15 |
| IL94692A0 (en) | 1991-04-15 |
| WO1990015819A1 (en) | 1990-12-27 |
| CA2034480A1 (en) | 1990-12-16 |
| JPH04500371A (ja) | 1992-01-23 |
| AU630715B2 (en) | 1992-11-05 |
| EP0428700A1 (en) | 1991-05-29 |
| NZ234011A (en) | 1992-11-25 |
| GB8913844D0 (en) | 1989-08-02 |
| AU5859690A (en) | 1991-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2084944T3 (es) | Amidas terapeuticas. | |
| ES2164663T3 (es) | Derivados de paclitaxel unidos a polimeros. | |
| BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
| FI923619A0 (fi) | Cykliska peptider och deras anvaendning. | |
| EA199800357A1 (ru) | Фармацевтические ангиостатические дипептидные композиции и способы их применения | |
| FR2669336B1 (fr) | Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| ES2148254T3 (es) | Peptidos antimicrobianos ciclicos y preparacion de los mismos. | |
| ES2061848T3 (es) | Compuestos triciclos, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden. | |
| EP0487502A3 (en) | Pharmaceutically active aryl-substituted amine derivatives | |
| ES2107035T3 (es) | Derivados de 3-azabiciclo(3.2.0)heptano n-substituidos como neurolepticos etc.. | |
| ES2045189T3 (es) | Nuevos agentes anti-arritmicos i. | |
| ES2133295T3 (es) | Peptidos ciclicos y su uso. | |
| RU98113920A (ru) | Производные олигопептидов, содержащие d-алкилтриптофан и способные активировать высвобождение гормона роста | |
| ES2056471T3 (es) | Antagonistas irreversibles de la bombesina. | |
| BG60101B2 (bg) | Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол | |
| EP0612530A3 (en) | A pharmaceutical composition containing cytotoxic factor for tumors. | |
| DE69918098D1 (de) | Neue suesstoffzusammensetzungen | |
| DE69932714D1 (de) | Suesstoffzusammensetzung | |
| ES2141096T3 (es) | Compuestos de cefalosporina y composiciones farmaceuticas de los mismos. | |
| ES2064525T3 (es) | Composicion alimenticia para cultivar peces. | |
| ES2117003T3 (es) | Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen. | |
| ATE106244T1 (de) | Iontophoresezusammensetzung zur erhöhung der hautkonzentration aktiver wirkstoffe. | |
| NO883520L (no) | Fremgangsmaate for fremstilling av et injeksjonspreparat. | |
| ATE109780T1 (de) | Heterocyclische verbindungen und antiulkusmittel. | |
| EA200001136A1 (ru) | Фунгицидные смеси |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 428700 Country of ref document: ES |